SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (20)7/14/1998 12:07:00 PM
From: Steve Lokness  Read Replies (2) | Respond to of 1475
 
Rick;

You seem to have an exceptional understanding of biotechs in general and also know BTRN. I agree with your last post. One of the things as you mentioned that is hurting these biotechs is that the VC money is bolting. BTRN has a huge divergence between their shares and the float; do you know who holds these shares? Are there VC's or other large holders that might sell even at these prices?

Thanks;
Steve



To: scaram(o)uche who wrote (20)7/15/1998 12:58:00 PM
From: Rudy Saucillo  Read Replies (1) | Respond to of 1475
 
BTI-322 Phase II data was presented at the Transplantation Society world congress:

biz.yahoo.com

Rudy